PA
MBOT icon

Perceptive Advisors’s Microbot Medical MBOT Stock Holding History

Perceptive Advisors’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-168
Closed -$551K – 136
2014
Q2 		$551K Hold
168
– – 0.05% 87
2014
Q1 		$364K Hold
168
– – 0.04% 98
2013
Q4 		$334K Buy
168
+25
+17% +$52.9K 0.04% 80
2013
Q3 		$389K Hold
143
– – 0.03% 81
2013
Q2 		$382K Buy
+143
New +$403K 0.04% 69

Other funds holding MBOT

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Perceptive Advisors's MBOT Position: Q3 2014 in Review

Perceptive Advisors sold out of Microbot Medical (MBOT) in Q3 2014, closing a stake of 168 shares — an estimated $551K sold.

Perceptive Advisors first reported a position in MBOT in Q2 2013 and held it in 5 quarters. The position peaked at $551K in Q2 2014. 39 funds tracked by Wall St. Rank hold MBOT as of Q3 2014.

  • Perceptive Advisors reported no remaining Microbot Medical position as of Q3 2014 after selling out during the quarter.
  • Perceptive Advisors sold 168 Microbot Medical shares in Q3 2014, an estimated $551K.
  • Perceptive Advisors first reported a position in Microbot Medical in Q2 2013 and held it in 5 quarters.
  • Perceptive Advisors's Microbot Medical position peaked at $551K in Q2 2014.
  • 39 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2014.

Based on Perceptive Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.